A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis

NCT02418845 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Vaginosis

Interventions

DRUG: SYM-1219
DRUG: Placebo

Sponsor

Symbiomix Therapeutics